Weight Loss

Glibenclamide is a drug used in some types of diabetes in which there is no normal insulin secretion. Insulin is responsible for controlling the level of sugar (glucose) in the blood. Mechanism of action Glibenclamide Stimulates insulin secretion by ß cells of the pancreas. Reduces hepatic glucose production and increases the binding and response capacity of insulin in peripheral tissues. Therapeutic indications Glibenclamide Type II diabetes mellitus when it cannot be controlled by diet, physical exercise and weight loss. Adjuvant to insulin in insulin-dependent diabetes.

Glimepiride 2 mg in a 30-tablet presentation is a medication used to treat type 2 diabetes mellitus. If discomfort persists, consult your doctor.

Self-monitoring test strips for measuring blood glucose levels, compatible with Gmate line meters. Image may vary depending on the final product and geographic area.

Self-monitoring test strips for measuring blood glucose levels, compatible with Gmate line meters. Image may vary depending on the final product and geographic area.

Glucose meter for continuous self-monitoring at home. The used test strip can be removed without touching it using the ejection function. Image may vary depending on the final product and geographic area.

Grape-flavored chewable tablets with a combination of 3 types of probiotics This product is not a medicine. The consumption of this product is the responsibility of the person recommending it and the person using it.

Insulin glargine 100 IU/ml injection (10 ml) is a long-acting (basal) synthetic insulin used to control high blood sugar levels in people with diabetes mellitus. Key features Active ingredient: Insulin glargine. Concentration: 100 International Units (IU) per milliliter (U-100). One 10 ml vial contains a total of 1000 units. Insulin type: Long-acting, also known as basal insulin. It provides a steady, peak-free concentration profile with a duration of action of approximately 18 to 24 hours. Presentation: Injectable solution in a 10 ml vial. Indications It is used to improve glycemic control in: Adults and children over 2 years of age with type 1 diabetes mellitus (always in combination with shorter-acting/rapid-acting mealtime insulin). Adults with type 2 diabetes mellitus. Not used to treat diabetic ketoacidosis. Administration and Dosage Route of administration: Subcutaneous (under the skin). Frequency: Usually injected once a day, at the same time every day. Injection site: The injection site should be rotated with each dose (e.g., abdomen, thigh, buttock, or upper arm) to reduce the risk of skin problems such as lipodystrophy (thickening or lumps in the skin). Dosage: The dose should be individualized and adjusted by a physician according to the patient's needs and blood glucose levels. Most common side effect The most frequent adverse reaction is hypoglycemia (low blood sugar), which can occur if the insulin dose is too high relative to the patient's needs. Common brand names Some brand names containing insulin glargine 100 IU/ml are Lantus® and Glaritus®. Important note: This medication should be used under strict medical supervision. Always follow your healthcare professional's instructions regarding dosage, timing of administration, and proper use of insulin syringes. This content is for informational purposes only. For medical advice or diagnosis, consult a professional. AI responses may contain errors. Learn more undefined undefined undefined 14 sites Learn how to inject | Lantus® (insulin glargine injection) 100 ... Translated — What is Lantus® (insulin glargine injection) 100 Units/mL? Prescription LANTUS is a long-acting synthetic insulin ... Page icon Lantus Drug details: Insulin-glargine - Pediamécum Jan 14, 2021 — Insulin glargine is a long-acting human insulin analogue, produced using DNA technology.

Probiotic capsules, with 1.666 billion CFU of Lactibacilli acidophilus, rhamnosus, and Bifidobacterium longum This product is not a medicine. The consumption of this product is the responsibility of the person recommending it and the person using it.

Lancets with sterilized tips, silicone-coated to prevent skin damage. Image may vary from final product and geographic area.

Linagliptin is an oral medication used to treat type 2 diabetes. It belongs to a class of drugs called dipeptidyl peptidase-4 (DPP-4) inhibitors. Uses of linagliptin Treatment of type 2 diabetes: Linagliptin, along with diet and exercise, helps improve blood glucose control in adults with type 2 diabetes. Monotherapy or combination therapy: It can be used as a single medication (monotherapy) or in combination with other oral antidiabetic drugs (such as metformin) and insulin, if needed. Mechanism of action: Linagliptin works by inhibiting the DPP-4 enzyme, which increases insulin release from the pancreas and decreases glucose production by the liver. This occurs in a way that is dependent on blood glucose levels. If discomfort persists, consult your doctor.

At the extrapancreatic level, glibenclamide reduces hepatic glucose production and enhances insulin action in peripheral tissues, primarily adipose and muscle tissue. It also has a mild diuretic effect and increases fluid clearance. If discomfort persists, consult your doctor.

Metformin/Glimepiride 850mg/4mg (extended release) is used to treat type 2 diabetes in adults, combining two blood sugar-lowering medications: metformin reduces glucose production, and glimepiride stimulates the pancreas to produce more insulin and improves its use. If discomfort persists, consult your doctor.

This combination of Metformin (850 mg) and Sitagliptin (50 mg) is a medication primarily indicated to improve blood sugar control in adult patients with type 2 diabetes mellitus. It serves the following specific purposes: Glycemic control: It is used in conjunction with diet and exercise when blood sugar is not adequately controlled with metformin alone or when the patient is already taking both medications separately. Dual mechanism of action: Metformin: Reduces glucose production in the liver and improves glucose sensitivity. If discomfort persists, consult your doctor.

This combination of Metformin (850 mg) and Sitagliptin (50 mg) is a medication primarily indicated to improve blood sugar control in adult patients with type 2 diabetes mellitus. It serves the following specific purposes: Glycemic control: It is used in conjunction with diet and exercise when blood sugar is not adequately controlled with metformin alone or when the patient is already taking both medications separately. Dual mechanism of action: Metformin: Reduces glucose production in the liver and improves glucose sensitivity. If discomfort persists, consult your doctor.

This combination of Metformin (850 mg) and Sitagliptin (50 mg) is a medication primarily indicated to improve blood sugar control in adult patients with type 2 diabetes mellitus. It serves the following specific purposes: Glycemic control: It is used in conjunction with diet and exercise when blood sugar is not adequately controlled with metformin alone or when the patient is already taking both medications separately. Dual mechanism of action: Metformin: Reduces glucose production in the liver and improves glucose sensitivity. If discomfort persists, consult your doctor.

The combination of Metformin/Vildagliptin (1000 mg/50 mg) is an oral antidiabetic medication indicated for the treatment of type 2 diabetes mellitus in adults who do not achieve adequate control with maximum doses of metformin alone or who are already using both drugs separately. If discomfort persists, consult your doctor.